2006 Frontiers Fund Career Development Award
“Mineralocorticoid Receptor Genotype and Potassium Response to Spironolactone”

“The Frontiers Career Development Award allowed me to explore a new line of research that may not have been possible through other funding mechanisms. The findings from the supported project have lead to a new line of research in my laboratory and have been used to support further grant applications. Additionally, this Award has resulted in new collaborations with ACCP members in other areas of research.”

2006 Frontiers Fund Career Development Award
“Impact of Fluoroquinolone Resistance on Pseudomonas Virulence and Patient Outcomes”

“The Frontiers Career Development Award has given me the financial support to generate pilot data with which to apply for federal funding. This award has brought recognition for the scholarship achievement of my clinical department within my school and externally as well.”

2006 Frontiers Fund Career Development Award
“Glucocorticoid Therapy for Acetaminophen-Induced Liver Toxicity”

“Receiving the Frontiers Career Development Award is an honor. It allowed me to obtain new research skills in the laboratory setting by working with basic scientists on murine-based experiments. The study provided insight into the inflammatory processes of acetaminophen-induced hepatotoxicity. While the hypothesis of these experiments proved false, the downstream result is that we now have a potentially new treatment modality that we are continuing to investigate. Should this modality ever prove promising, it will be the Career Development Award that initiated this line of research. From a career development point-of-view, my goal is to develop a research program that bridges “benchtop” research with “bedside” research and I believe the skills I developed with the recently completed Career Development Award will help me transform my clinical research program into an experimental-therapeutic program.”

2004 Frontiers Fund Career Development Award
“Topical Phosphoinositides to Prevent Acute Lung Injury”

“The support provided by the ACCP-sponsored Career Development Award was instrumental in moving a new project forward to the point that it is now being prepared as an RO1 submission in June of 2008. Along the way, we published two solid manuscripts (possibly a third) and several abstracts were presented at international meetings. It also served as partial support for a graduate student who has now completed her studies and will obtain her Ph.D. in pharmaceutics in the spring. Her success with this project was instrumental in landing a position at the FDA. As you can see, many productive things were accomplished through the support provided by ACCP.”

I remember a time during my fellowship training (years ago) where I was informed that my project was too basic for funding consideration by ACCP. Since this time, it is clear that ACCP has embraced a larger spectrum for what it will consider as fundable research. This is something that I am proud to be a part of.”

2004 Frontiers Fund Career Development Award & 2004 Investigator Development Research Award
“Evaluation of Diabetic Nephropathy in Hispanic Americans”

2003 Investigator Development Research Award
“Immunosuppressant effects on p-glycoprotein function in HK-2 cells”

“Our Frontiers Fund award has provided vital resources to our research team, including 2 ACCP members, a clinical sciences graduate student, and a physician co-investigator. These funds were used to obtain important preliminary data, conduct new genotyping methods, and assemble a research team that will work together on future projects in underserved populations.“

2006 Frontiers Fund Career Development Award
“Uncoupling Protein Polymorphisms and Acute Coronary Syndrome Outcomes”

“As a junior investigator, ACCP’s Frontiers Fund helped me at a critical time during my career. In less than two years after receiving my Frontiers Fund Career Development Research Award, I have received a fundable score on my NIH K23 grant, according to historical pay lines. Awards such those provided by ACCP are vital to the success of young investigators, especially as we face tough times with NIH budget cuts and falling pay lines. Multiple NIH grant submissions are now the rule instead of the exception and these awards allow for continuity in our research and in the training of students.”

2005 Frontiers Fund Career Development Award
“Genetic Polymorphisms and Vascular Access Thrombosis”

“The Frontiers Fund grant I received helped establish my research program in thrombosis and hemostasis in patients with chronic kidney disease. This study served as pilot data for my pending NIH grant application.”

2006 Frontiers Fund Career Development Award
“Outcomes of a Pharmacist-Initiated Step-Down Protocol for Antimicrobials”

“The Frontiers Career Development Award was the first major grant I received as an independent researcher post-fellowship. The project I did would have been impossible without the grant, so I am forever grateful for the award. The grant also made it possible for me to mentor a pharmacy resident during her residency year while she assisted with the study. The results of the study were presented as a platform presentation at the annual meeting of the IDSA as well as the ACCP Annual Meeting and led to a number of interviews for publication in healthcare professional news media.”

2004 Frontiers Fund Career Development Award
“Improving the Quality of Medication Use in Older Adults”

“The Frontiers Career Development Award provided timely funding to initiate work proposed in a 5-year NIH K23 Research and Career Development application under review at the National Institutes on Aging. The receipt of the Frontiers award provided the funding needed to begin Aim 1 of the proposed studies and provided preliminary data to strengthen my NIH application. I remain convinced that receipt of the Frontiers Career Development Award contributed to my success in obtaining the NIH K23 award a year later.”

2005 Frontiers Fund Career Development Award
“Optimizing the Treatment of Recurrent Ovarian Cancer”

“I am grateful for the support I received from the ACCP Frontier's Fund Investigator's Award. This seed funding provided me with an opportunity to conduct studies that I would not otherwise been able to do. The preliminary data made it possible for me to obtain additional peer review funding and has ultimately lead to a pilot study in patients. I think is it so important for ACCP to foster and support the development of young pharmacy investigators.”

2007 Frontiers Fund Career Development Award
“fMRI Imaged Neuroactivation & Craving in Alcoholics is Modulated by Ondansetron”

“I was fortunate to have been selected as a Frontiers Award winner and wish to explain how this award will facilitate my career. I have been involved with nasal drug delivery research for some time and had been considering different drug candidates for various therapeutic purposes. I have been impressed with the degree that alcohol related abuse disorders are so pervasive and that we do not have good pharmacotherapeutic options. In reviewing drug therapy it occurred to me that most treatment is chronic suppressive therapy. My idea was to determine if there was a role for PRN medication administration in the disorder spectrum. I needed a new tool to determine the acute effects of medications on alcohol abusers neurophysiology, and discovered that MRI, and functional MRI, may be good tools but had not been studied in drug treatment of alcoholism. I submitted this grant proposal to ACCP and then one to NIH using a similar construct. I was fortunate to hear from ACCP and am able to take what I learned here to re-apply to NIH to develop this tool. NIH was supportive and wanted pilot data and so this grant will give me the data I need to go back for a competitive grant with NIAAA. “

2003 Frontiers Fund Career Development Award
“P-glycoprotein and renal clearance of antibiotics in cystic fibrosis”

“The ACCP Career Development Award provided vital funding to support the initiation of a focused area of clinical research. The application and review process provided me with the confidence to submit additional grants and improved my grant writing abilities.”

2006 Frontiers Fund Career Development Award
“Risperidone-Induced Prolactin Elevation and Bone Turnover in Adolescents”

2006 Investigator Development Award
“The Relationship of COMT with Cognition and Symptom Response to Risperidone in First Episode Schizophrenia”

“The ACCP Frontiers Career Development Award has been an instrumental part of the development of my research program. It provided funding for an important research project that has already yielded pilot data that I have used to support recent federal grant applications. The Career Development Award also provided me with an opportunity to learn new research techniques that will facilitate future research studies and grant applications.“

2007 Frontiers Fund Career Development Award
“HIV Positive Women’s Interactions with Pharmacy Systems”

"The ACCP Frontiers Career Development Award has helped to support me in my transition from clinical pharmacist to clinical scientist. While many pharmacists exercise their clinical skills on a daily basis, there is often little in the way of resources available to help pharmacists efficiently merge clinical practice with their research interests. ACCP Frontiers Career Development Award helps to fill this need. My award has encouraged many other new practitioners to consider applying and has illustrated to my students that pharmacy research is an important field."

"The Frontier’s Award has been instrumental in my research involving understanding the disposition of cyclophosphamide and mycophenolic acid and impact of pharmacogenomics in lupus nephritis patients. The award was instrumental in obtaining data that nicely complements my K23 award which is being conducted in another model of glomerulonephritis. The two studies have enabled a most detailed dataset regarding glomerulonephritis and impact of drug disposition and pharmacogenomics on treatment-related outcomes. The ACCP Research Institute and the K23 Career Development grant will be instrumental in helping me to gain a competitive edge in the NIH process. I congratulate ACCP in their endeavors to pave the way for pharmacists to become successful researchers."